RBC Capital Upgrades IGM Biosciences (IGMS) to Outperform, 'Pivoting Towards Becoming Key Player In Emerging Autoimmune Space'
Tweet Send to a Friend
(Updated - February 9, 2024 7:45 AM EST)
RBC Capital analyst Brian Abrahams upgraded IGM Biosciences (NASDAQ: IGMS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams upgraded IGM Biosciences (NASDAQ: IGMS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
